Radiancy psoriasis therapy:
This article was originally published in Clinica
Executive Summary
The US FDA has given Radiancy 510(k) clearance to market its phototherapy for psoriasis, which is based on its proprietary Light Heat Energy technology. The psoriasis light unit assembly (LUA) has been shown in clinical studies to be a safe and effective treatment for mild to moderate plaque and guttate psoriases, said the Orangeburg, New York firm; patients in the study showed an average reduction of 65% on the Psoriasis Severity Index (PSI). Radiancy said that LHE-based phototherapy systems were already cleared in the US for removing hair and treating acne vulgaris and pigmented and vascular lesions on all skin types and that the modular psoriasis LUA could be attached quickly to the systems.